Journal
NEUROLOGY
Volume 58, Issue 11, Pages 1680-1682Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.58.11.1680
Keywords
-
Categories
Ask authors/readers for more resources
The authors report a double-blind, placebo-controlled, crossover study of talampanel in 49 patients with refractory partial seizures. Three doses of talampanel were investigated based on differences in patients' concomitant antiepileptic drug usage. Talampanel showed efficacy in reducing seizure frequency (p = 0.001) with a median seizure reduction of 21%. Eighty percent of patients had fewer seizures on talampanel than on placebo. Dizziness (52%) and ataxia (26%) were the only significant adverse events.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available